ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity

Matteo Massara, Ornella Bonavita, Benedetta Savino, Nicoletta Caronni, Valeria Mollica Poeta, Marina Sironi, Elisa Setten, Camilla Recordati, Laura Crisafulli, Francesca Ficara, Alberto Mantovani, Massimo Locati and Raffaella Bonecchi ()
Additional contact information
Matteo Massara: Humanitas Clinical and Research Center
Ornella Bonavita: Humanitas Clinical and Research Center
Benedetta Savino: Humanitas Clinical and Research Center
Nicoletta Caronni: Humanitas Clinical and Research Center
Valeria Mollica Poeta: Humanitas Clinical and Research Center
Marina Sironi: Humanitas Clinical and Research Center
Elisa Setten: Humanitas Clinical and Research Center
Camilla Recordati: Fondazione Filarete
Laura Crisafulli: Humanitas Clinical and Research Center
Francesca Ficara: Humanitas Clinical and Research Center
Alberto Mantovani: Humanitas Clinical and Research Center
Massimo Locati: Humanitas Clinical and Research Center
Raffaella Bonecchi: Humanitas Clinical and Research Center

Nature Communications, 2018, vol. 9, issue 1, 1-11

Abstract: Abstract Atypical chemokine receptors (ACKRs) are regulators of leukocyte traffic, inflammation, and immunity. ACKR2 is a scavenger for most inflammatory CC chemokines and is a negative regulator of inflammation. Here we report that ACKR2 is expressed in hematopoietic precursors and downregulated during myeloid differentiation. Genetic inactivation of ACKR2 results in increased levels of inflammatory chemokine receptors and release from the bone marrow of neutrophils with increased anti-metastatic activity. In a model of NeuT-driven primary mammary carcinogenesis ACKR2 deficiency is associated with increased primary tumor growth and protection against metastasis. ACKR2 deficiency results in neutrophil-mediated protection against metastasis in mice orthotopically transplanted with 4T1 mammary carcinoma and intravenously injected with B16F10 melanoma cell lines. Thus, ACKR2 is a key regulator (checkpoint) of mouse myeloid differentiation and function and its targeting unleashes the anti-metastatic activity of neutrophils in mice.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-03080-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03080-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-03080-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().